NASDAQ · Medical - Devices

AHCO (AHCO) Stock

$11.17 -0.45% NASDAQ: AHCO Healthcare

Valuation

MetricValue
Price$11.17
Market Cap$1.52B
P/E Ratio8.52
P/B Ratio0.88
P/S Ratio0.48
EPS (TTM)$-0.52
52-Week High$13.43
52-Week Low$8.06
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-4.85%
ROA2.64%
ROCE12.18%
Gross Margin5.38%
Operating Margin7.26%
Net Margin-2.78%
Debt/Equity1.33
Current Ratio1.02

Annual Financials (USD)

Metric20212022202320242025
Revenue$2.5B$3.0B$3.2B$3.3B$3.2B
Operating Profit$226.0M$190.0M$-598.0M$264.0M$186.0M
Net Profit$156.0M$69.0M$-679.0M$90.0M$-71.0M
EPS$0.67$0.50$-5.31$0.61$-0.52
Op Margin9.2%6.4%-18.7%8.1%5.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$5.3B$5.2B$4.5B$4.5B$4.3B
Total Liabilities$3.2B$3.1B$3.0B$2.9B$2.8B
Cash$150.0M$46.0M$77.0M$110.0M$106.0M
Borrowings$2.4B$2.3B$2.3B$2.1B$1.9B

Latest News

AHCO: What does Argus have to say about AHCO? Argus Research · Jul 15, 2026 AdaptHealth Corp. Announces Second Quarter 2026 Earnings Release Date and Conference Call Business Wire · Jul 14, 2026 AdaptHealth discloses patient data was stolen in cyberattack MedTech Dive · Jul 7, 2026 AdaptHealth discloses June cyberattack resulting in patient data exposure Medical Device Network · Jul 6, 2026 AdaptHealth Reports Material Cybersecurity Incident MT Newswires · Jul 2, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$276.0M$374.0M$481.0M$542.0M$602.0M
Investing Cash Flow$-2.0B$-803.0M$-695.0M$-616.0M$-686.0M
Financing Cash Flow$-76.0M$-30.0M$-41.0M$-19.0M$-35.0M
Net Cash Flow$50.0M$-103.0M$31.0M$33.0M$-4.0M
Free Cash Flow$72.0M$-18.0M$143.0M$236.0M$219.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA5.69
FCF Yield14.09%
Quick Ratio0.71
Interest Coverage1.75
Return 1Y8.61%
Return 3Y-24.30%
Return 5Y-60.44%

Ownership

Insiders Held8.14%
Institutions Held106.71%
Institutions Float Held116.17%
Institutional HolderSharesReport Date
OEP Capital Advisors, LP16,312,6982026-03-31
Blackrock Inc.15,939,9532026-03-31
Deerfield Management Company, L.P11,477,7302026-03-31
Skyknight Capital, L.p.8,580,4432026-03-31
FMR, LLC8,054,6912026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMPH $20.22 +1.40% 12.02 $891.56M 0.00%
BBNX $15.90 +12.69% -6.53 $715.34M 0.00%
CNMD $44.24 -0.02% 19.34 $1.33B 1.17%
CVACCureVac N.V. $4.66 +0.00% 5.69 $1.05B 0.00%
ESTA $92.80 +0.28% -38.58 $2.73B 0.00%

About AHCO

AHCO is led by CEO Suzanne Foster, employs 10,500 people, headquartered in US, publicly traded since 2018.

AHCO stock trades at $11.17 with a market capitalization of $1.52B. The stock is valued at a price-to-earnings (P/E) ratio of 8.52, price-to-book of 0.88, price-to-sales of 0.48. Over the past 52 weeks the stock has ranged between $8.06 and $13.43, and currently trades 16.8% below its 52-week high.

On profitability, AHCO generates a return on equity (ROE) of -4.85%, return on capital employed of 12.18%, an operating margin of 7.26%, a net profit margin of -2.78%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides